motus gi holdings, inc. (nasdaq: mots) is a medical technology company based in the u.s., with subsidiaries in the u.s. and israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. the company is focused on the development and commercialization of the pure-vu® system, designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. the pure-vu® system is a 510(k) u.s. food and drug administration cleared medical device indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. the device integrates with standard colonoscopes to enable cleaning during the procedure while preserving standard procedural workflow and techniques. the pure-vu® system has received ce mark approval in europe.
Company profile
Ticker
MOTS
Exchange
Website
CEO
Timothy Moran
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Eight-Ten Merger Corp.
SEC CIK
Corporate docs
Subsidiaries
Motus GI Medical Technologies, Ltd. • Motus GI, LLC ...
MOTS stock data
Latest filings (excl ownership)
S-3
Shelf registration
22 Mar 24
10-K
2023 FY
Annual report
18 Mar 24
8-K
Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results
18 Mar 24
8-K
Departure of Directors or Certain Officers
11 Mar 24
8-K
Submission of Matters to a Vote of Security Holders
7 Mar 24
8-K
Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds
22 Feb 24
8-K
Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract
21 Feb 24
DEFA14A
Additional proxy soliciting materials
16 Feb 24
DEF 14A
Definitive proxy
24 Jan 24
8-K
Other Events
22 Jan 24
Transcripts
MOTS
Earnings call transcript
2022 Q3
14 Nov 22
MOTS
Earnings call transcript
2022 Q2
12 Aug 22
MOTS
Earnings call transcript
2022 Q1
13 May 22
MOTS
Earnings call transcript
2021 Q4
30 Mar 22
MOTS
Earnings call transcript
2021 Q3
12 Nov 21
MOTS
Earnings call transcript
2021 Q2
13 Aug 21
MOTS
Earnings call transcript
2021 Q1
14 May 21
MOTS
Earnings call transcript
2020 Q4
17 Mar 21
MOTS
Earnings call transcript
2020 Q3
12 Nov 20
MOTS
Earnings call transcript
2020 Q2
11 Aug 20
Latest ownership filings
4
Scott Durbin
13 Mar 24
4
Sonja Nelson
13 Mar 24
4
Gary J Pruden
13 Mar 24
4
Timothy P. Moran
12 Mar 24
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 24
3
Initial statement of insider ownership
22 Sep 23
SC 13G
Orchestra BioMed Holdings, Inc.
22 Sep 23
4
Scott Durbin
6 Sep 23
3
Scott Durbin
6 Sep 23
3
Ravit Ram
21 Jun 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 5.72 mm | 5.72 mm | 5.72 mm | 5.72 mm | 5.72 mm | 5.72 mm |
Cash burn (monthly) | 932.33 k | 630.83 k | 798.00 k | 1.12 mm | 655.00 k | 1.11 mm |
Cash used (since last report) | 5.56 mm | 3.76 mm | 4.76 mm | 6.69 mm | 3.90 mm | 6.64 mm |
Cash remaining | 167.94 k | 1.96 mm | 968.48 k | -961.35 k | 1.82 mm | -918.64 k |
Runway (months of cash) | 0.2 | 3.1 | 1.2 | -0.9 | 2.8 | -0.8 |
Institutional ownership, Q2 2023
10.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 12 |
Opened positions | 2 |
Closed positions | 5 |
Increased positions | 3 |
Reduced positions | 3 |
13F shares | Current |
---|---|
Total value | 268.40 mm |
Total shares | 516.40 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Armistice Capital | 272.99 k | $182.90 mm |
Larry N Feinberg | 105.89 k | $53.00 k |
Perceptive Advisors | 90.03 k | $60.32 mm |
Geode Capital Management | 18.56 k | $12.43 mm |
Tower Research Capital | 12.14 k | $8.13 mm |
Commonwealth Equity Services | 10.00 k | $7.00 k |
Advisor | 3.50 k | $2.34 mm |
BLK Blackrock | 2.62 k | $1.75 mm |
MS Morgan Stanley | 650.00 | $436.00 k |
WFC Wells Fargo & Co. | 39.00 | $26.00 k |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Mar 24 | Moran Timothy P. | Stock Option Common Stock, par value $0.0001 per share | Grant | Acquire A | No | No | 0.622 | 23,205 | 14.43 k | 23,205 |
5 Mar 24 | Nelson Sonja | Stock Option Common Stock, par value $0.0001 per share | Grant | Acquire A | No | No | 0.622 | 23,205 | 14.43 k | 23,205 |
5 Mar 24 | Gary J Pruden | Stock Option Common Stock, par value $0.0001 per share | Grant | Acquire A | No | No | 0.622 | 23,205 | 14.43 k | 23,205 |
5 Mar 24 | Scott Durbin | Stock Option Common Stock, par value $0.0001 per share | Grant | Acquire A | No | No | 0.622 | 23,205 | 14.43 k | 23,205 |
News
Motus GI Hldgs Q4 EPS $(4.48) Misses $(4.39) Estimate, Sales $64.00K Miss $150.00K Estimate
18 Mar 24
Why Intuitive Machines Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket
26 Feb 24
12 Health Care Stocks Moving In Monday's Pre-Market Session
26 Feb 24
12 Health Care Stocks Moving In Friday's After-Market Session
23 Feb 24
12 Health Care Stocks Moving In Thursday's Intraday Session
22 Feb 24
Press releases
Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
18 Mar 24
EndoSound™ Inc., Appoints Medical Device Commercial Leader Scott Aldrich Jr as Chief Executive Officer
29 Feb 24
Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract
21 Feb 24
Motus GI Holdings, Inc. Announces Adjournment of the February 16, 2024 Special Meeting of Stockholders
16 Feb 24